|
TSLA
|
Consumer Cyclical |
JP Morgan |
Maintains
|
Neutral
→
Neutral
|
—
|
$1.4T
|
$11.68
|
+2.7%
|
+0.9%
|
-14.5%
|
-7.5%
|
-1.3%
|
+4.9%
|
|
TSLA
|
Consumer Cyclical |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$1.4T
|
$11.68
|
+2.7%
|
+0.9%
|
-14.5%
|
-7.5%
|
-1.3%
|
+4.9%
|
|
TSLA
|
Consumer Cyclical |
Goldman Sachs |
Maintains
|
Neutral
→
Neutral
|
—
|
$1.4T
|
$11.68
|
+2.7%
|
+0.9%
|
-14.5%
|
-7.5%
|
-1.3%
|
+4.9%
|
|
TSLA
|
Consumer Cyclical |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$1.4T
|
$11.68
|
+2.7%
|
+0.9%
|
-14.5%
|
-7.5%
|
-1.3%
|
+4.9%
|
|
TSLA
|
Consumer Cyclical |
Stifel |
Maintains
|
Hold
→
Hold
|
—
|
$1.4T
|
$11.68
|
+2.7%
|
+0.9%
|
-14.5%
|
-7.5%
|
-1.3%
|
+4.9%
|
|
BAC
|
Financial Services |
Bernstein |
Maintains
|
Market Perform
→
Market Perform
|
—
|
$386.6B
|
$14.04
|
-0.4%
|
-0.8%
|
+0.2%
|
-1.1%
|
+3.8%
|
+0.6%
|
|
UNH
|
Healthcare |
Monness Crespi Hardt |
Downgrade
|
Buy
→
Neutral
|
—
|
$354.2B
|
$68.95
|
-0.7%
|
-0.3%
|
+2.3%
|
-0.8%
|
+1.1%
|
+0.0%
|
|
UNH
|
Healthcare |
Monness, Crespi, Hardt |
Downgrade
|
Buy
→
Neutral
|
—
|
$354.2B
|
$68.95
|
-0.7%
|
-0.3%
|
+2.3%
|
-0.8%
|
+1.1%
|
+0.0%
|
|
DIS
|
Communication Services |
Wunderlich |
Maintains
|
Hold
→
Hold
|
—
|
$185.2B
|
$68.81
|
-0.1%
|
+0.1%
|
+0.2%
|
-2.7%
|
+2.1%
|
-0.3%
|
|
DIS
|
Communication Services |
Wunderlich Securities |
Maintains
|
Hold
→
Hold
|
—
|
$185.2B
|
$68.81
|
-0.1%
|
+0.1%
|
+0.2%
|
-2.7%
|
+2.1%
|
-0.3%
|
|
UBS
|
Financial Services |
MainFirst Bank AG |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$150.6B
|
$18.16
|
-1.0%
|
+0.1%
|
+1.3%
|
-2.0%
|
+1.2%
|
+0.8%
|
|
UBS
|
Financial Services |
MainFirst |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$150.6B
|
$18.16
|
-1.0%
|
+0.1%
|
+1.3%
|
-2.0%
|
+1.2%
|
+0.8%
|
|
BKNG
|
Consumer Cyclical |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$128.1B
|
$42.82
|
+0.0%
|
+1.1%
|
-2.2%
|
-3.3%
|
+4.9%
|
+2.2%
|
|
BKNG
|
Consumer Cyclical |
BofA Securities |
Maintains
|
Buy
→
Buy
|
—
|
$128.1B
|
$42.82
|
+0.0%
|
+1.1%
|
-2.2%
|
-3.3%
|
+4.9%
|
+2.2%
|
|
CI
|
Healthcare |
Monness Crespi Hardt |
Downgrade
|
Buy
→
Neutral
|
—
|
$77.5B
|
$79.61
|
-0.6%
|
-0.1%
|
+1.1%
|
-1.4%
|
+1.8%
|
+0.5%
|
|
CI
|
Healthcare |
Monness, Crespi, Hardt |
Downgrade
|
Buy
→
Neutral
|
—
|
$77.5B
|
$79.61
|
-0.6%
|
-0.1%
|
+1.1%
|
-1.4%
|
+1.8%
|
+0.5%
|
|
REGN
|
Healthcare |
Leerink Swann |
Maintains
|
Outperform
→
Outperform
|
—
|
$68.5B
|
$281.70
|
+5.6%
|
+7.3%
|
-4.6%
|
-3.9%
|
+2.2%
|
-1.4%
|
|
REGN
|
Healthcare |
Deutsche Bank |
Maintains
|
Buy
→
Buy
|
—
|
$68.5B
|
$281.70
|
+5.6%
|
+7.3%
|
-4.6%
|
-3.9%
|
+2.2%
|
-1.4%
|
|
REGN
|
Healthcare |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$68.5B
|
$281.70
|
+5.6%
|
+7.3%
|
-4.6%
|
-3.9%
|
+2.2%
|
-1.4%
|
|
HUM
|
Healthcare |
Monness, Crespi, Hardt |
Downgrade
|
Buy
→
Neutral
|
—
|
$37.5B
|
$94.13
|
-0.5%
|
-0.2%
|
+2.0%
|
-0.4%
|
-0.3%
|
+1.0%
|